{
    "info": {
        "nct_id": "NCT04831580",
        "official_title": "A Randomized Controlled Trial of Robotic Versus Open Surgery for Early Stage Cervical Cancer (ROCC)",
        "inclusion_criteria": "1. Patient must have histologically confirmed adenocarcinoma (usual/classic/NOS), squamous cell carcinoma, adenosquamous carcinoma (Including glassy cell)\n2. Patient must be FIGO Stage IA2, IBI, IB2 (2018 staging) without evidence of definitive parametrial, vaginal, nodal or distant metastases on exam or imaging. Patients with tumor size less than or equal to 4 cm confirmed on MRI prior to randomization are eligible.\n3. Patient must have uterine size <12 cm AND felt to be appropriate for vaginal delivery of the specimen per investigator.\n4. Patient must be suitable surgical candidate with preoperative assessments such as labs and EKG performed per institutional standard and agree to be randomized to undergo open or robotic radical (or simple) hysterectomy.\n\n   NOTE: Simple hysterectomy will be allowed in patients who meet the following criteria:\n   1. pelvic MRI must demonstrate a maximal tumor size of 2 cm or less AND\n   2. less than 50% stromal invasion on MRI if tumor present or less than 10 mm of stromal invasion if an excisional (cold knife or LEEP) has been performed.\n\n   Submission of source documents in the GOG Partners Source Document Portal will be required prior to randomization for review and confirmation of simple hysterectomy being met (see Section 6.0 for instructions).\n5. Patient must be age 18 years or older.\n6. Patient must have ECOG performance status 0-1.\n7. Patient must have a negative urine pregnancy test within 30 days of surgery in pre-menopausal women.\n8. Patient must have signed an approved informed consent and authorization permitting the release of personal health information.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Patients with any tumor histology other than those listed above, specifically excluding the following histologies: neuroendocrine, other adenocarcinoma (gastric type, endometrioid, clear cell, serous, signet ring, minimal deviation)\n2. Patients with FIGO stage 1A1, IB3, II-IV (2018 staging).\n3. Patient with inability to receive an MRI.\n4. Patients with a tumor size greater than 4cm or on MRI confirmed prior to randomization are excluded. Patients with definite evidence of vaginal/parametrial involvement on MRI are excluded; if MRI findings are not definitive, then clinical examination must also not reveal parametrial or vaginal extension).\n5. Patients with evidence of metastatic disease (imaging or histologically positive lymph nodes).\n6. Patients with a history of prior pelvic or abdominal radiotherapy.\n7. Patients with a prior malignancy < 5 years from enrollment with the exception of non-melanoma skin cancer.\n8. Patients who are unable to withstand prolonged lithotomy or steep trendelenberg.\n9. Patient compliance and geographic proximity that do not allow adequate follow-up.\n10. Patients with poorly controlled HIV with CD4 counts <500.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must be FEMALE",
            "criterions": [
                {
                    "exact_snippets": "Must be FEMALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Patient must have ECOG performance status 0-1.",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status 0-1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Patient must have signed an approved informed consent and authorization permitting the release of personal health information.",
            "criterions": [
                {
                    "exact_snippets": "Patient must have signed an approved informed consent",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "signed",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "approval status",
                            "expected_value": "approved"
                        }
                    ]
                },
                {
                    "exact_snippets": "authorization permitting the release of personal health information",
                    "criterion": "authorization for release of personal health information",
                    "requirements": [
                        {
                            "requirement_type": "authorization",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Patient must be FIGO Stage IA2, IBI, IB2 (2018 staging) without evidence of definitive parametrial, vaginal, nodal or distant metastases on exam or imaging. Patients with tumor size less than or equal to 4 cm confirmed on MRI prior to randomization are eligible.",
            "criterions": [
                {
                    "exact_snippets": "Patient must be FIGO Stage IA2, IBI, IB2 (2018 staging)",
                    "criterion": "FIGO stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "IA2",
                                "IB1",
                                "IB2"
                            ]
                        },
                        {
                            "requirement_type": "staging_system",
                            "expected_value": "2018"
                        }
                    ]
                },
                {
                    "exact_snippets": "without evidence of definitive parametrial, vaginal, nodal or distant metastases on exam or imaging",
                    "criterion": "metastases",
                    "requirements": [
                        {
                            "requirement_type": "location",
                            "expected_value": [
                                "parametrial",
                                "vaginal",
                                "nodal",
                                "distant"
                            ]
                        },
                        {
                            "requirement_type": "evidence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "tumor size less than or equal to 4 cm confirmed on MRI prior to randomization",
                    "criterion": "tumor size",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "cm"
                            }
                        },
                        {
                            "requirement_type": "confirmation_method",
                            "expected_value": "MRI"
                        }
                    ]
                }
            ]
        },
        {
            "line": "NOTE: Simple hysterectomy will be allowed in patients who meet the following criteria:",
            "criterions": [
                {
                    "exact_snippets": "Simple hysterectomy will be allowed",
                    "criterion": "simple hysterectomy",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Patient must be suitable surgical candidate with preoperative assessments such as labs and EKG performed per institutional standard and agree to be randomized to undergo open or robotic radical (or simple) hysterectomy.",
            "criterions": [
                {
                    "exact_snippets": "Patient must be suitable surgical candidate",
                    "criterion": "surgical candidacy",
                    "requirements": [
                        {
                            "requirement_type": "suitability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "preoperative assessments such as labs and EKG performed per institutional standard",
                    "criterion": "preoperative assessments",
                    "requirements": [
                        {
                            "requirement_type": "completion",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "labs",
                                "EKG"
                            ]
                        },
                        {
                            "requirement_type": "standard",
                            "expected_value": "per institutional standard"
                        }
                    ]
                },
                {
                    "exact_snippets": "agree to be randomized to undergo open or robotic radical (or simple) hysterectomy",
                    "criterion": "agreement to randomization and surgery",
                    "requirements": [
                        {
                            "requirement_type": "agreement",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "surgery type",
                            "expected_value": [
                                "open radical hysterectomy",
                                "robotic radical hysterectomy",
                                "open simple hysterectomy",
                                "robotic simple hysterectomy"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Patient must have a negative urine pregnancy test within 30 days of surgery in pre-menopausal women.",
            "criterions": [
                {
                    "exact_snippets": "negative urine pregnancy test",
                    "criterion": "urine pregnancy test",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    ]
                },
                {
                    "exact_snippets": "within 30 days of surgery",
                    "criterion": "timing of urine pregnancy test",
                    "requirements": [
                        {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days before surgery"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "in pre-menopausal women",
                    "criterion": "menopausal status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "pre-menopausal"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. pelvic MRI must demonstrate a maximal tumor size of 2 cm or less AND",
            "criterions": [
                {
                    "exact_snippets": "pelvic MRI must demonstrate a maximal tumor size of 2 cm or less",
                    "criterion": "maximal tumor size (on pelvic MRI)",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "cm"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. less than 50% stromal invasion on MRI if tumor present or less than 10 mm of stromal invasion if an excisional (cold knife or LEEP) has been performed.",
            "criterions": [
                {
                    "exact_snippets": "less than 50% stromal invasion on MRI if tumor present",
                    "criterion": "stromal invasion (on MRI)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 50,
                                "unit": "%"
                            }
                        },
                        {
                            "requirement_type": "assessment_method",
                            "expected_value": "MRI"
                        },
                        {
                            "requirement_type": "tumor_presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "less than 10 mm of stromal invasion if an excisional (cold knife or LEEP) has been performed",
                    "criterion": "stromal invasion (on excisional specimen)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 10,
                                "unit": "mm"
                            }
                        },
                        {
                            "requirement_type": "procedure",
                            "expected_value": [
                                "cold knife",
                                "LEEP"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Patient must have histologically confirmed adenocarcinoma (usual/classic/NOS), squamous cell carcinoma, adenosquamous carcinoma (Including glassy cell)",
            "criterions": [
                {
                    "exact_snippets": "histologically confirmed adenocarcinoma (usual/classic/NOS)",
                    "criterion": "adenocarcinoma",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "subtype",
                            "expected_value": [
                                "usual",
                                "classic",
                                "NOS"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "histologically confirmed ... squamous cell carcinoma",
                    "criterion": "squamous cell carcinoma",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "histologically confirmed ... adenosquamous carcinoma (Including glassy cell)",
                    "criterion": "adenosquamous carcinoma",
                    "requirements": [
                        {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "subtype",
                            "expected_value": [
                                "glassy cell"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Patient must be age 18 years or older.",
            "criterions": [
                {
                    "exact_snippets": "Patient must be age 18 years or older",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Patient must have uterine size <12 cm AND felt to be appropriate for vaginal delivery of the specimen per investigator.",
            "criterions": [
                {
                    "exact_snippets": "uterine size <12 cm",
                    "criterion": "uterine size",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": "<",
                                "value": 12,
                                "unit": "cm"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "felt to be appropriate for vaginal delivery of the specimen per investigator",
                    "criterion": "appropriateness for vaginal delivery of the specimen",
                    "requirements": [
                        {
                            "requirement_type": "investigator assessment",
                            "expected_value": "appropriate"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Submission of source documents in the GOG Partners Source Document Portal will be required prior to randomization for review and confirmation of simple hysterectomy being met (see Section 6.0 for instructions).",
            "criterions": [
                {
                    "exact_snippets": "confirmation of simple hysterectomy being met",
                    "criterion": "simple hysterectomy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "2. Patients with FIGO stage 1A1, IB3, II-IV (2018 staging).",
            "criterions": [
                {
                    "exact_snippets": "Patients with FIGO stage 1A1, IB3, II-IV (2018 staging)",
                    "criterion": "FIGO stage (2018)",
                    "requirements": [
                        {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "1A1",
                                "IB3",
                                "II",
                                "III",
                                "IV"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Patients with any tumor histology other than those listed above, specifically excluding the following histologies: neuroendocrine, other adenocarcinoma (gastric type, endometrioid, clear cell, serous, signet ring, minimal deviation)",
            "criterions": [
                {
                    "exact_snippets": "Patients with any tumor histology other than those listed above, specifically excluding the following histologies: neuroendocrine, other adenocarcinoma (gastric type, endometrioid, clear cell, serous, signet ring, minimal deviation)",
                    "criterion": "tumor histology",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": [
                                "neuroendocrine",
                                "adenocarcinoma (gastric type)",
                                "adenocarcinoma (endometrioid)",
                                "adenocarcinoma (clear cell)",
                                "adenocarcinoma (serous)",
                                "adenocarcinoma (signet ring)",
                                "adenocarcinoma (minimal deviation)"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Patients with evidence of metastatic disease (imaging or histologically positive lymph nodes).",
            "criterions": [
                {
                    "exact_snippets": "evidence of metastatic disease",
                    "criterion": "metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "imaging or histologically positive lymph nodes",
                    "criterion": "positive lymph nodes",
                    "requirements": [
                        {
                            "requirement_type": "detection method",
                            "expected_value": [
                                "imaging",
                                "histology"
                            ]
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "10. Patients with poorly controlled HIV with CD4 counts <500.",
            "criterions": [
                {
                    "exact_snippets": "poorly controlled HIV",
                    "criterion": "HIV control",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "poorly controlled"
                        }
                    ]
                },
                {
                    "exact_snippets": "CD4 counts <500",
                    "criterion": "CD4 count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 500,
                                "unit": ""
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Patients who are unable to withstand prolonged lithotomy or steep trendelenberg.",
            "criterions": [
                {
                    "exact_snippets": "unable to withstand prolonged lithotomy",
                    "criterion": "ability to withstand prolonged lithotomy position",
                    "requirements": [
                        {
                            "requirement_type": "tolerance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "unable to withstand ... steep trendelenberg",
                    "criterion": "ability to withstand steep trendelenburg position",
                    "requirements": [
                        {
                            "requirement_type": "tolerance",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Patient compliance and geographic proximity that do not allow adequate follow-up.",
            "criterions": [
                {
                    "exact_snippets": "Patient compliance ... do not allow adequate follow-up",
                    "criterion": "patient compliance",
                    "requirements": [
                        {
                            "requirement_type": "adequacy for follow-up",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "geographic proximity ... do not allow adequate follow-up",
                    "criterion": "geographic proximity",
                    "requirements": [
                        {
                            "requirement_type": "adequacy for follow-up",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Patients with a prior malignancy < 5 years from enrollment with the exception of non-melanoma skin cancer.",
            "criterions": [
                {
                    "exact_snippets": "prior malignancy < 5 years from enrollment",
                    "criterion": "prior malignancy",
                    "requirements": [
                        {
                            "requirement_type": "time since prior malignancy diagnosis",
                            "expected_value": {
                                "operator": "<",
                                "value": 5,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "with the exception of non-melanoma skin cancer",
                    "criterion": "non-melanoma skin cancer",
                    "requirements": [
                        {
                            "requirement_type": "exception to exclusion",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Patient with inability to receive an MRI.",
            "criterions": [
                {
                    "exact_snippets": "inability to receive an MRI",
                    "criterion": "ability to receive MRI",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Patients with a tumor size greater than 4cm or on MRI confirmed prior to randomization are excluded. Patients with definite evidence of vaginal/parametrial involvement on MRI are excluded; if MRI findings are not definitive, then clinical examination must also not reveal parametrial or vaginal extension).",
            "criterions": [
                {
                    "exact_snippets": "tumor size greater than 4cm",
                    "criterion": "tumor size",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">",
                                "value": 4,
                                "unit": "cm"
                            }
                        },
                        {
                            "requirement_type": "exclusion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "MRI confirmed prior to randomization",
                    "criterion": "MRI confirmation prior to randomization",
                    "requirements": [
                        {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "exclusion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "definite evidence of vaginal/parametrial involvement on MRI",
                    "criterion": "vaginal/parametrial involvement on MRI",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "exclusion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "if MRI findings are not definitive, then clinical examination must also not reveal parametrial or vaginal extension",
                    "criterion": "parametrial or vaginal extension on clinical examination (if MRI not definitive)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "conditional",
                            "expected_value": "Only applies if MRI findings are not definitive"
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Patients with a history of prior pelvic or abdominal radiotherapy.",
            "criterions": [
                {
                    "exact_snippets": "history of prior pelvic or abdominal radiotherapy",
                    "criterion": "prior pelvic or abdominal radiotherapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}